Breaking News: Daraxonrasib Approved for Pancreatic Cancer
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets...
In this video, some of the best minds in cancer research discuss the need for cancer research and cancer...
In a study published Tuesday in the American Association for Cancer Research’s journal Clinical Cancer Research, researchers identified two...
Today we released the fourth annual AACR Cancer Progress Report. I am thrilled at the level of interest already...
Early-career scientists are the future of cancer research. Those who reach the postdoctoral level have already shown their extraordinary...
The American Association for Cancer Research (AACR) often participates in cancer-related Twitter chats, and we welcome Twitter novices and...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention confirms that there is no increased risk...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...
The Stand Up To Cancer (SU2C) telecast on Friday, Sept. 5, is an important vehicle to fund highly meritorious...
Researchers have observed that diabetes seems to increase the risk of getting certain cancer types. In the summer issue...
Adults who smoked reduced-nicotine cigarettes did not smoke more intensely to compensate for the lower levels of nicotine, according...